La catena delle opzioni mostra i dati chiave delle opzioni azionarie di BioCardia a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per BioCardia..

BioCardia (NASDAQ:BCDA) Azioni, Catena delle Opzioni

BioCardia

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

BioCardia Inc

RBC Capital analyst Arthur Nagorny reiterates Mattr (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MATR#TSX">MATR</a>) with a Outperform and maintains C$18 price target.

News

Price Target

Reiteration

Analyst Ratings

TSX:MATR

RBC Capital Reiterates Outperform on Mattr, Maintains C$18 Price Target

Stock Split

J-Long Group Announces 1-For-10 Reverse Stock Split

JP Morgan analyst Anne Samuel maintains Evolent Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) with a Overweight and lowers the price target from $45 to $15.

JP Morgan Maintains Overweight on Evolent Health, Lowers Price Target to $15

Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) shares are trading higher on Friday. The company has agreed to sell its Personal Protective Equipment (PPE) business to Protective Industrial Products, Inc. (PIP) for <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42135452/honeywell-to-sell-personal-protective-equipment-business-to-protective-industrial-products" rel="noreferrer noopener">$1.325 billion in an all-cash deal</a>.
This move aligns with Honeywell&#8217;s strategy to streamline its portfolio, focusing on core businesses and pursuing high-return acquisitions that support its three key megatrends: automation, the future of aviation, and energy transition.
This sale follows Honeywell&#8217;s 2021 divestiture of its Lifestyle and Performance Footwear Business to Rocky Brands for $230 million, marking the company&#8217;s exit from the PPE sector.
However, Honeywell will retain its gas detection portfolio within the Industrial Automation segment.
The sale of the PPE business is expected to close in the first half of 2025, pending customary conditions.
Vimal Kapur, Chairman and CEO of Honeywell said, &#8221;Now with this transaction, the business will be positioned to accelerate its growth trajectory as it benefits from Odyssey&#8217;s historic investing in the PPE sector and scaling similar businesses&nbsp;to expand into new products, geographies and end markets.&#8221;
&#8220;As we continue to simplify and optimize Honeywell&#8217;s portfolio, the sale of the PPE business will enable us to further strengthen our core business in alignment with our three compelling megatrends.&#8221;
&#8221;The combination of today&#8217;s announcement, with the strategic acquisitions we have made over the past year, positions us to continue to drive profitable growth and strong cash generation while creating compelling long-term value for our shareowners.&#8221;
Last month, Honeywell announced a plan to spin off its Advanced Materials business into an independent, U.S. publicly traded company, which is targeted to be <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41223435/honeywell-announces-plan-to-spin-off-advanced-materials-business-to-shareowners" rel="noreferrer noopener">completed by the end of 2025 or early 2026.</a>
Honeywell held cash and equivalents of about&nbsp;$10.6 billion as of <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41516652/honeywells-mixed-q3-eps-beats-misses-on-sales-and-lowers-fy24-revenue-outlook" rel="noreferrer noopener">September 30, 2024</a>.
Investors can gain exposure to the stock via&nbsp;Amplify CWP Enhanced Dividend Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIVO#NYSE">DIVO</a>) and&nbsp;Invesco Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPA#NYSE">PPA</a>).
Price Action: HON shares are up 1.01% at $228.38 at the last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42137748" target="_blank" rel="noreferrer noopener">Amid Ongoing Browser Antitrust Scrutiny In US, UK Might Be Next To Challenge Apple And Google&#8217;s Duopoly</a></li>
</ul>

Equities

Large Cap

Asset Sales

DIVO

Honeywell Cashes Out: $1.325 Billion PPE Business Sale Fuels Bold Portfolio Transformation

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

CBOE

Cboe To Launch First Cash-Settled Spot Bitcoin Index Options On December 2, Expanding Investor Access To Crypto Derivatives

JP Morgan analyst Andrew Steinerman maintains Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) with a Neutral and raises the price target from $15 to $16.

VSTS

JP Morgan Maintains Neutral on Vestis, Raises Price Target to $16

Elon Musk and <a href="https://www.benzinga.com/startups/24/11/42038767/im-one-of-you-how-anti-woke-warrior-vivek-ramaswamy-became-a-billionaire-at-only-38">Vivek Ramaswamy</a> have been appointed to lead a new <a href="https://www.benzinga.com/news/24/11/42026862/musk-and-ramaswamy-seek-spending-cut-wins-where-others-failed">government-efficiency commission</a> created by Donald Trump. The stated goal is to cut government spending and one approach being considered involves reducing or eliminating certain federal agencies.&nbsp;
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
As Business Insider reports, while Ramaswamy expects to &#8220;delete&#8221; whole government agencies, Musk emphasized that the plan is not to leave people without support but to streamline the federal workforce in areas they consider &#8220;bloated.&#8221; He has mentioned the possibility of offering severance packages of up to two years&#8217; pay to those affected.
According to official government data, 2,278,730 Americans worked for the federal government as of March 2024. Some departments are significantly larger than others. For example, the <a href="https://www.benzinga.com/24/11/42021130/with-doug-collins-as-va-leader-whats-next-for-cannabis-and-psychedelics-in-veterans-healthcare">Department of Veterans Affairs</a> employs nearly half a million people, while the Department of Education has just over 4,000 employees. Within the Treasury Department, most of the 100,000+ employees work for the Internal Revenue Service (IRS).
Departments with more than 100,000 employees:
<ul>
<li>Department of Veterans Affairs (486,522)</li>
<li>Department of Homeland Security (222,539)</li>
<li>Department of the Army (221,037)</li>
<li>Department of the Navy (216,537) </li>
<li>Department of the Air Force (168,505)</li>
<li>Department of Defense (156,803)</li>
<li>Department of Justice (116,614)</li>
<li>Department of the Treasury (108,869)</li>
</ul>
See Also: ‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a>
Many federal workers earn competitive salaries, with most departments offering six-figure averages. The Department of Education <a href="https://www.benzinga.com/markets/equities/24/09/40963177/us-department-of-energy-to-invest-3b-in-battery-production">and Energy</a> tend to have the highest average salaries among government agencies, at $144,561 and $143,486, respectively.
Departments with the highest average salary:
<ul>
<li>Department of Education ($144,561)</li>
<li>Department of Energy ($143,486)</li>
<li>Department of Transportation ($139,474)</li>
<li>Department of Housing and Urban Development ($134,503)</li>
<li>Department of State ($132,587)</li>
<li>Department of Health and Human Services ($130,117)</li>
</ul>
This is not the first time a commission like this has been formed. According to Business Insider, Ronald Reagan had the Grace Commission in the 1980s, which aimed to find waste and inefficiencies in federal spending. However, it is important to note that Musk and Ramaswamy&#8217;s new effort does not have the authority to make these changes on its own – it will need Congress to back its recommendations.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We are very grateful to the thousands of Americans who have expressed interest in helping us at DOGE. We don't need more part-time idea generators. We need super high-IQ small-government revolutionaries willing to work 80+ hours per week on unglamorous cost-cutting. If that's…
&mdash; Department of Government Efficiency (@DOGE) <a href="https://twitter.com/DOGE/status/1857076831104434289?ref_src=twsrc%5Etfw">November 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
To fulfill their goals, <a href="https://www.benzinga.com/news/24/11/41998717/elon-musk-and-vivek-ramaswamy-are-looking-for-high-iq-small-government-revolutionaries-who-are-willing-to-put-in-80-hours-at-doge">Musk and Ramaswamy are seeking</a> &#8220;super high-iQ small-government revolutionaries&#8221; to help reduce federal inefficiencies under President-elect Donald Trump. DOGE&#8217;s official account on X posted a call for applicants willing to work 80+ hours a week to streamline government spending and cut bureaucracy. Interested candidates are encouraged to DM their CVs, with Musk and Ramaswamy supposedly personally reviewing the top 1% of applicants.
While Musk and Ramaswamy&#8217;s approach aims to make the government &#8220;leaner&#8221; and potentially more efficient, there are significant concerns regarding the impact of such drastic cuts. Eliminating entire agencies could result in disruptions to essential public services, affecting everything from health care to education to veterans&#8217; support. The loss of federal jobs could also have a broader economic impact, particularly in regions where government employment forms a significant part of the local economy.&nbsp;
Read Next:
<ul>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">You can still get 4,000 of its pre-IPO shares for with $1,000 for just $0.25/share</a></li>
</ul>

With Musk And Ramaswamy Preparing To Slash Entire Government Agencies, Here's Which Departments Employ The Most Americans And Their Salaries

In the current session, the stock is trading at $145.85, after a 0.73% spike. Over the past month, Cava Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) stock increased by 7.08%, and in the past year, by 333.82%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1732288513_0.png" alt="Past Year Chart" />

<h3>Cava Group P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Cava Group has a better P/E ratio of 353.17 than the aggregate P/E ratio of 69.6 of the Hotels, Restaurants &amp; Leisure industry. Ideally, one might believe that Cava Group Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1732288513_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

CAVA

Price Over Earnings Overview: Cava Group

JP Morgan analyst Matthew Boss maintains Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) with a Neutral and raises the price target from $26 to $28.

JP Morgan Maintains Neutral on Gap, Raises Price Target to $28

JP Morgan analyst Matthew Boss maintains Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) with a Overweight and raises the price target from $171 to $173.

ROST

JP Morgan Maintains Overweight on Ross Stores, Raises Price Target to $173

Keybanc analyst Jason Celino maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Overweight and raises the price target from $68 to $85.

PCOR

Keybanc Maintains Overweight on Procore Technologies, Raises Price Target to $85

Stifel analyst Simon Yarmak upgrades Pebblebrook Hotel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) from Hold to Buy and raises the price target from $14.75 to $15.

Upgrades

Stifel Upgrades Pebblebrook Hotel to Buy, Raises Price Target to $15

JP Morgan analyst Alexei Gogolev maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Overweight and raises the price target from $75 to $85.

JP Morgan Maintains Overweight on Procore Technologies, Raises Price Target to $85

Stifel analyst Simon Yarmak downgrades Diamondrock Hospitality (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRH#NYSE">DRH</a>) from Buy to Hold and lowers the price target from $10.75 to $10.25.

Downgrades

Stifel Downgrades Diamondrock Hospitality to Hold, Lowers Price Target to $10.25

DIRECTV announced Friday it would terminate its agreement to acquire EchoStar Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) <a href="https://www.prnewswire.com/news-releases/directv-announces-termination-of-agreement-to-acquire-echostars-video-distribution-business-302313823.html" target="_blank" rel="noreferrer noopener">video distribution business, DISH DBS</a>. 
The decision follows DISH DBS noteholders&#8217; refusal to accept EchoStar&#8217;s proposed Exchange Debt Offer Terms, a critical condition for the deal to proceed. 
EchoStar stock tanked after the update.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42137930/boeing-secures-238-billion-deal-for-advanced-kc-46a-tankers" rel="noreferrer noopener">Boeing Secures $2.38 Billion US Air Force Deal for Advanced KC-46A Tankers</a>
DirecTV CEO Bill Morrow said &#8220;the proposed Exchange Terms were necessary to protect DirecTV&#8217;s balance sheet and our operational flexibility.&#8221;
DirecTV <a target="_blank" href="https://www.benzinga.com/news/24/09/41094002/echostar-stock-dives-on-directv-dish-deal-the-details" rel="noreferrer noopener">agreed to acquire</a> EchoStar&#8217;s video business for $1 and assume Dish DBS&#8217;s net debt. The companies launched an exchange offer for five Dish DBS note series totaling approximately $9.75 billion in face value.
DirecTV plans to continue investing in next-generation streaming technologies and developing new packaging options integrating live TV with direct-to-consumer platforms. The company aims to provide customers with enhanced flexibility and tailored content options that align with evolving viewer preferences.
The termination of the DISH acquisition does not impact TPG&#8217;s plan to purchase the remaining 70% stake in DirecTV from AT&amp;T Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>), which remains scheduled to close in the second half of 2025. This strategic move is expected to strengthen DirecTV&#8217;s market positioning further.
EchoStar reported a <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41905346/echostar-q3-earnings-and-sales-falter-but-gains-ground-with-sling-tv-subscribers" rel="noreferrer noopener">third-quarter loss</a> of 52 cents per share, missing analysts&#8217; expected loss of 37 cents. Revenue came in at $3.89 billion, a 5.3%, falling short of the $3.909 billion consensus estimate.
During the quarter, net Pay-TV subscribers declined by 43,000, while Sling TV added 145,000 new users. The company closed the period with 8.03 million Pay-TV subscribers, including 5.89 million for DISH TV and 2.14 million for Sling TV.
Price Action: EchoStar&#8217;s shares are trading lower by 3% to $22.86 at last check Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42137039/disney-takes-on-netflix-with-high-impact-originals-in-asia" target="_blank" rel="noreferrer noopener">Disney Takes on Netflix With High-Impact Originals in Asia</a></li>
</ul>
Image via DirecTV

SATS

EchoStar Shares Sink As DirecTV Terminates Acquisition Agreement

Keybanc analyst Jackson Ader maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Overweight and raises the price target from $345 to $395.

CRWD

Keybanc Maintains Overweight on CrowdStrike Holdings, Raises Price Target to $395

JP Morgan analyst Jeremy Tonet maintains Pembina Pipeline (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PPL#TSX">PPL</a>) with a Neutral and raises the price target from C$62 to C$63.

TSX:PPL

JP Morgan Maintains Neutral on Pembina Pipeline, Raises Price Target to C$63

Stifel analyst Selman Akyol maintains Spire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SR#NYSE">SR</a>) with a Hold and lowers the price target from $70 to $69.

Stifel Maintains Hold on Spire, Lowers Price Target to $69

Stifel analyst Adam Borg maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Buy and raises the price target from $70 to $84.

Stifel Maintains Buy on Procore Technologies, Raises Price Target to $84

Stifel analyst Matthew Sheerin maintains NetApp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>) with a Buy and raises the price target from $140 to $145.

NTAP

Stifel Maintains Buy on NetApp, Raises Price Target to $145

BioCardia shares climb as it gets FDA clearance for its Morph DNA product family

Catalyst Watch: FOMC, FedEx earnings, Electronic Arts event, and triple witching day

Wall Street Breakfast: The Week Ahead

BioCardia regains compliance with Nasdaq Capital Market

BioCardia (BCDA) announced the completion of its last protocol specified follow-up visit in CardiAMP HF, a prospective, randomized, double-blinded,...

BioCardia completes last protocol specified follow-up visit in CardiAMP HF

Analyst Joseph Pantginis of H.C. Wainwright maintained a Buy rating on BioCardia (BCDA – Research Report), retaining the price target of $25.00. Jo...

Promising Outlook for BioCardia with Advancements in CardiAMP HF Program and Personalized Treatment Approach

BioCardia GAAP EPS of -$0.61 beats by $0.58

BioCardia, Inc. (BCDA) Q3 2024 Earnings Call Transcript

BioCardia (BCDA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from H.C....

BioCardia's Strong Q3 Performance and Strategic Trials Drive Buy Rating

Option delistings effective November 18th include BioCardia (BCDA), DBV Technologies (DBVT), ACN 650 026 314 Ltd (DCFCQ), DouYu International (DOYU...

Eleven option delistings on November 18th

ALAB

ALTM

ASTS

AVGO

BCDA

BCDAW

BIRK

BLDP

BYDDF

CART

CSCO

CYBN

DBVT

DECK

DOYU

ELTP

EXPD

FCEL

FERG

FFIE

FSLR

HUBS

INTZ

LSTR

MSFT

NVDA

PETQ

PLCE

PLUG

QCOM

RBLX

RDDT

SBUX

SCPX

SEDG

SGBX

SHAK

STLA

TMUS

TSLA

USAU

VTLE

WDAY

ZVRA

Press Releases

BioCardia to Host Q2 2024 Corporate Update and Financial Results Conference Call on August 13, 2024

Earnings

BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results

FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment

Health Care

General

BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family

Financing

BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules

BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules

BioCardia Regains Full Compliance with Nasdaq Listing Requirements

BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure

BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024

Comments

BioCardia

BioCardia (BCDA) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO